Market Place
Sourcing Support
Tiefenbacher Group Renovation Of Headquarters In Hamburg
02 May 2024 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.
09 Apr 2024 //
PRESS RELEASE
Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate
08 Apr 2024 //
PRESS RELEASE
Tiefenbacher Group awarded the EcoVadis Silver Medal!
19 Mar 2024 //
PRESS RELEASE
Tiefenbacher Group on awareness for rare disease day
29 Feb 2024 //
PRESS RELEASE
Tiefenbacher Group Renovation of our Headquarters
14 Feb 2024 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide
27 Sep 2023 //
PRESS RELEASE
New Websites Online
06 Jun 2023 //
PRESS RELEASE
Successful Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority
10 May 2023 //
PRESS RELEASE
Tiefenbacher Pharma Successfully Launches The Antihistamine Bilastine
14 Mar 2023 //
PRESS RELEASE
Tiefenbacher Manufacturing Sites Have Been Successfully Registered By The UAE
25 Feb 2023 //
PRESS RELEASE
Tiefenbacher Successfully Launches Generic Version Of The Psoriasis Apremilast
01 Dec 2022 //
PRESS RELEASE
Thanks For Visiting Us At Cphi 2022 In Frankfurt!
10 Nov 2022 //
PRESS RELEASE
Tiefenbacher Group Opens New Manufacturing Site In Cyprus
28 Oct 2022 //
PRESS RELEASE
Tiefenbacher Group And Ondosis Are Thrilled To Announce The Launch Of Oysta®
25 Oct 2022 //
PRESS RELEASE
Tiefenbacher Pharma Successfully Launches Generic Version Apixaban In Canada
20 Oct 2022 //
PRESS RELEASE
Meet Tiefenbacher At Cphi In Frankfurt From 1-3 Nov & Discover Our Latest Ideas
04 Oct 2022 //
PRESS RELEASE
Meet Tiefenbacher Group At Bepharma In Mexico City From October 10-12!
15 Sep 2022 //
PRESS RELEASE
Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin
08 Sep 2022 //
PRESS RELEASE
Environmentally Friendly And Health-Promoting: Tiefenbacher Group Offers Bike
18 Aug 2022 //
PRESS RELEASE
Tiefenbacher Expands The Launch Of The Anticoagulant Medicine Rivaroxaban
15 Jul 2022 //
PRESS RELEASE
Tiefenbacher Launches 1st Generic Version Of MS Medicine Teriflunomide In Canada
02 Jun 2022 //
PRESS RELEASE
Tiefenbacher Group Becomes Member Of (Psci)
24 May 2022 //
PRESS RELEASE
Tiefenbacher Group Opens New Site For Highly Potent Drugs In India
05 May 2022 //
PRESS RELEASE
Four Drugs Recommended For Approval By Chmp At April Meeting
25 Apr 2022 //
MEDWATCH
World Health Day @ Tiefenbacher Group
07 Apr 2022 //
PRESS RELEASE
Tiefenbacher Group At Dcat 2022 – Thanks For Meeting Us In New York City!
29 Mar 2022 //
PRESS RELEASE
New Launch: Tiefenbacher Pharma Successfully Launches First Generic Version
22 Mar 2022 //
PRESS RELEASE
Tiefenbacher Group Stands With Ukraine
09 Mar 2022 //
PRESS RELEASE
Tiefenbacher Group Stands With Ukraine
08 Mar 2022 //
PRESS RELEASE
Meet Tiefenbacher Group During Dcat Week In New York City From 21-24Th March!
09 Feb 2022 //
PRESS RELEASE
Tiefenbacher Group Wishes A Happy And Healthy Year 2022 From All Over The World!
04 Jan 2022 //
PRESS RELEASE
Tiefenbacher Group Wishes A Happy And Healthy New Year 2022 From All Over
04 Jan 2022 //
PRESS RELEASE
Driving Efficiency Is Key Tiefenbacher Group Enlarges Manufacturing Facilities
15 Dec 2021 //
PRESS RELEASE
Driving efficiency is our key – TIEFENBACHER GROUP its MFG facilities De15, 2021
15 Dec 2021 //
PRESS RELEASE
Lupin launches Posaconazole DRT after alliance partner AET Pharma
20 Nov 2021 //
INDIAINFOLINE
Three successful days for TIEFENBACHER GROUP at CPhI 2021 –Milano!T
17 Nov 2021 //
PRESS RELEASE
At TIEFENBACHER GROUP giving back to society is important to us
25 Oct 2021 //
PRESS RELEASE
Reach Out To Tiefenbacher Group At Cphi In Milan From 9-11Th Nov And Discover
06 Oct 2021 //
PRESS RELEASE
Reach out to TIEFENBACHER GROUP at CPhI in Milan from 9-11th Nov
06 Oct 2021 //
PRESS RELEASE
New market launch - tiefenbacher group
20 Sep 2021 //
PRESS RELEASE
Tiefenbacher API + Ingredients Secures The Supply Of Controlled Substances For Customers And Patients
22 Jun 2021 //
PRESS RELEASE
New Agreement Expands Collaboration Between Ondosis And Tiefenbacher Group
26 May 2021 //
PRESS RELEASE
New Agreement Expands Collaboration Between Ondosis And Tiefenbacher Group
19 May 2021 //
PRESS RELEASE
Spreading Of Post Covid-19 Disease "Black Fungus“ In India – Tiefenbacher Group Supports With Posaconazole Tablets
19 May 2021 //
PRESS RELEASE
Tiefenbacher API + Ingredients Offers Pitavastatine Calcium For Novel Therapies
11 May 2021 //
PRESS RELEASE
Tiefenbacher Group Announces Global Launch Of Tiefenbacher Medical Devices
16 Apr 2021 //
PRESS RELEASE
Tiefenbacher API + Ingredients Starts To Offer The First Api Based On Green Chemistry
15 Apr 2021 //
PRESS RELEASE
Lupin unveils Posaconazole Delayed-Release Tablets
18 Feb 2021 //
MEDICAL DIALOGUES
Aet Pharma Us Inc. Announces Successful Approval Of Generic Posaconazole By The Food And Drug Administration (FDA)
08 Feb 2021 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Announces Global Launch Of Rivaroxaban
26 Jan 2021 //
PRESS RELEASE
International Brand Relaunch Of Tiefenbacher Group
02 Oct 2020 //
PRESS RELEASE
